Related Experiment Video
Updated: Jun 18, 2025
In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
The Restriction Activity Investigation of Rv2528c, an Mrr-like Modification-Dependent Restriction Endonuclease from
Tong Liu1, Wei Wei2, Mingyan Xu1
1Hebei Province Key Laboratory of Occupational Health and Safety for Coal Industry, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
Abstract:
Mycobacterium tuberculosis (Mtb), as a typical intracellular pathogen, possesses several putative restriction-modification (R-M) systems, which restrict exogenous DNA's entry, such as bacterial phage infection. Here, we investigate Rv2528c, a putative Mrr-like type IV restriction endonuclease (REase) from Mtb H37Rv, which is predicted to degrade methylated DNA that contains m6A, m5C, etc. Rv2528c shows significant cytotoxicity after being expressed in Escherichia coli BL21(DE3)pLysS strain. The Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay indicates that Rv2528c cleaves genomic DNA in vivo. The plasmid transformation efficiency of BL21(DE3)pLysS strain harboring Rv2528c gene was obviously decreased after plasmids were in vitro methylated by commercial DNA methyltransferases such as M.EcoGII, M.HhaI, etc. These results are consistent with the characteristics of type IV REases. The in vitro DNA cleavage condition and the consensus cleavage/recognition site of Rv2528c still remain unclear, similar to that of most Mrr-family proteins. The possible reasons mentioned above and the potential role of Rv2528c for Mtb were discussed.
Insights
Mycobacterium tuberculosis Rv2528c, a type IV restriction enzyme, degrades methylated DNA and shows cytotoxicity, suggesting a role in restricting foreign DNA entry. This enzyme cleaves genomic DNA in vivo, impacting bacterial defense mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Microbiology
Background:
- Mycobacterium tuberculosis (Mtb) employs restriction-modification (R-M) systems to defend against foreign DNA, such as bacteriophages.
- Rv2528c is a putative Mrr-like type IV restriction endonuclease (REase) in Mtb H37Rv, predicted to target methylated DNA (m6A, m5C).
Purpose of the Study:
- To investigate the function and characteristics of the Rv2528c restriction endonuclease from Mtb.
- To assess the impact of Rv2528c expression on host cell viability and DNA integrity.
- To evaluate Rv2528c's activity against methylated DNA substrates.
Main Methods:
- Expression of Rv2528c in Escherichia coli BL21(DE3)pLysS.
- Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay to detect DNA cleavage in vivo.
- Plasmid transformation efficiency assays using methylated and unmethylated DNA.
Main Results:
- Rv2528c expression induced significant cytotoxicity in E. coli.
- TUNEL assay confirmed Rv2528c-mediated genomic DNA cleavage in vivo.
- Transformation efficiency of methylated plasmids was significantly reduced in E. coli expressing Rv2528c.
Conclusions:
- Rv2528c functions as a type IV restriction endonuclease, degrading methylated DNA.
- The enzyme exhibits cytotoxic effects and cleaves DNA in vivo, consistent with a role in host defense.
- Further research is needed to elucidate Rv2528c's specific cleavage site and recognition sequence.
